Insulin Aspart NDC 70518-3865

Product information

Brand name (proprietary)

Insulin Aspart

Generic name (nonproprietary)

insulin aspart

Active ingredients

Insulin aspart — 100 [iU]/mL

Dosage form

Injection, Solution

Route

Intravenous, Subcutaneous

Labeler

REMEDYREPACK INC.

Product type

Prescription drug

Marketing category

BLA — Biologics License ApplicationApplication BLA 020986

Marketing start

Sep 18, 2023

Listing expires

Dec 31, 2027

Other FDA classes

Insulin (Chemical structure)

Identifiers

Product ID 70518-3865_485a3f8d-de3a-d94f-e063-6294a90ac25fSPL ID 485a3f8d-de3a-d94f-e063-6294a90ac25fSPL set ID b3d77cb0-cd47-441f-8f54-5329c655da9cRxCUI 1653202UNII D933668QVX

Pharmacologic class

Insulin Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470518386500 followed by a unit qualifier and the quantity Copy

Package 70518-3865-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under BLA 020986

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.